Related Experiment Videos
Pregnancy and rheumatoid arthritis
1Program in Immunogenetics, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Rheumatic Diseases Clinics of North America
|February 1, 1997
Summary
Pregnancy often improves rheumatoid arthritis (RA) symptoms, with relief starting in the first trimester. However, RA typically returns within months after delivery, though pregnancy itself doesn't harm outcomes.
Area of Science:
- Rheumatology and Immunology
- Reproductive Medicine
- Clinical Obstetrics
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting joints.
- Pregnancy is known to influence the course of many autoimmune conditions.
- Understanding RA's behavior during and after pregnancy is crucial for patient management.
Purpose of the Study:
- To investigate the impact of pregnancy on the amelioration and recurrence of rheumatoid arthritis.
- To examine how pregnancy affects the risk of developing rheumatoid arthritis for the first time.
- To assess the safety of RA medications during pregnancy and lactation.
Main Methods:
- Review of existing literature and clinical data on rheumatoid arthritis in pregnant women.
- Analysis of disease course, including symptom improvement and postpartum recurrence.
- Evaluation of pregnancy outcomes and risks associated with rheumatoid arthritis.
Main Results:
- Approximately 75% of women experience rheumatoid arthritis symptom improvement during pregnancy, often starting in the first trimester.
- Rheumatoid arthritis typically recurs within 3-4 months postpartum.
- Pregnancy reduces the risk of new-onset rheumatoid arthritis, but this risk increases postpartum before decreasing later.
Conclusions:
- Pregnancy generally has a positive, albeit temporary, effect on established rheumatoid arthritis.
- Pregnancy influences the incidence of new-onset rheumatoid arthritis, with a distinct postpartum risk pattern.
- Limited RA medications are considered safe for use during pregnancy and lactation, ensuring fetal well-being.